Ophthalmic Ultrasound Devices Generates over 1/4th of the Revenue through A-Scan, Reveals Fact.MR

Growing incidence of lifestyle- and age-related ophthalmic conditions and an increasing number of diabetic retinopathy in developed as well as developing regions are expected to enhance the product demand. Comments a Fact.MR analyst.

Fact.MR – A Market Research and Competitive Intelligence Provider: The Ophthalmic Ultrasound Devices Market revenues were estimated at US$ 432.2 Mn in 2021 and is anticipated to grow at a CAGR of 9.0% from 2022-2032, according to a recently published Fact.MR report. By the end of 2032, the market is expected to reach US$ 1.1 Bn.

In ophthalmology, ultrasound technology is being widely used to treat a range of disorders, including glaucoma, retinal issues, and cancer. The ophthalmic ultrasonography industry has incorporated new technologies to increase the diagnostic capabilities of their instruments. Improved electronics, such as improved transducers, and new technologies, such as linear array-based plane-wave ultrasound, have undoubtedly broadened the toolkits of ophthalmologists and eye surgeons.

The increased frequency of eye diseases such as diabetic retinopathy and cataracts, as well as new product developments, are projected to move the market forward. The availability of effective reimbursement mechanisms such as Medicare and Medicaid is projected to boost market expansion.

For more insights into the Market, Get A Sample of this Report!


Key Takeaways from the Market Study

  • Global Ophthalmic Ultrasound Devices Market is expected to reach a market size of US$ 467.9 Mn by 2022.
  • The A-Scan, is expected to have the highest CAGR rate of 9.1% during the forecast period.
  • United States to remain the most dominant market with absolute dollar growth opportunity of US$ 200 Mn.
  • The market in Japan to experience the highest CAGR of 12.8% during the 2022-2032 forecast period.

Competitive Landscape

The leading players in ophthalmic ultrasound devices market are focusing on growth strategies, such as innovations in the existing product, frequent product launches, and mergers & acquisitions.

  • In March 2019, Quantal medical received U.S. FDA approval for the launch of its product called ABSolu.
  • In April 2019, Lantheus announced in April that it would combine its microbubble technology with Cerevast's ocular ultrasound device for the treatment of retinal vascular occlusion. This could be an entryway for newer RVO technologies in the years ahead, which may increase the effective use of recently developed ophthalmic ultrasound systems. Cerevast's investigational ocular ultrasound program is undergoing a Phase 2b clinical trial in the second quarter of 2019.

For Comprehensive Insights Ask An Analyst Here


Market Segments Covered in Ophthalmic Ultrasound Devices Market Analysis

  • By Product Type
    • B-Scan
    • A-Scan
    • Combined
    • Pachymeter
    • Ultrasound Bio Microscope
  • By Mobility
    • Portable
    • Standalone
  • By End Use
    • Hospitals
    • Ambulatory Surgery Centers
    • Ophthalmology Clinics
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the Ophthalmic Ultrasound Devices Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032. The study reveals extensive growth in Ophthalmic Ultrasound Devices Market on the basis of Product (B-Scan, A-Scan, Combined, Pachymeter, Ultrasound Bio Microscope), Mobility (Portable, Standalone), End Use (Hospitals, Ambulatory Surgery Centers, Ophthalmology Clinics, Others) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Get Customization on this Report for Specific Research Solution:


About the Healthcare and Pharmaceutical Division at Fact.MR

Expert analysis, actionable insights, and strategic recommendations of the highly seasoned healthcare and pharma team at Fact.MR helps clients from across the globe with their unique business intelligence needs. With a repertoire of over thousand reports and 1 million-plus data points, the team has analyzed the healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Check out more studies related to Healthcare Industry, conducted by Fact.MR:

NGS Sample Preparation Market - NGS Sample Preparation Market Analysis Report By Product Type (Instruments, Kits, Reagents & Consumables), By Application (Drug & Biomarker Discovery, Diagnostics, Precision Medicines), By End User, By Region - Global Forecast 2022-2032

Osteoporosis Therapeutics Market - Osteoporosis Therapeutics Market Analysis by Drug Class (Bisphosphonates, Selective Estrogen Inhibitor Modulators (SERM), Parathyroid Hormone Therapies), by Route of Administration (Oral, Injectable), by Region - Global Forecast 2022-2026

CNS Therapeutics Market - Central Nervous System (CNS) Therapeutics Market Analysis by Segment (Pain Management CNS Therapeutics, Anti-psychotics, Anti-depressants, Anti-epilepsy, Anti-Alzheimer’s, Anti-Parkinson’s), by Region - Global Forecast 2022-2026

Induced Pluripotent Stem Cell (iPSC) Market - Induced Pluripotent Stem Cell (iPSC) Market Analysis by Cell Type (Vascular Cells, Cardiac Cells, Neuronal Cells, Liver Cells, Immune Cells), by Research Method (Cellular Reprogramming, Cell Culture, Cell Differentiation, Cell Analysis), by Application & Region - Global Forecast 2022-2026

Newborn Screening Market - Newborn Screening Market by Product (Instruments, Consumables), by Test Type (Dry Blood Spot Tests, Hearing Tests, CCHD Screening Tests), by Technology (Immunoassays & Enzymatic Screening Tests, Molecular Assays, Pulse Oximetry), by End User & Region - Global Forecast 2022-2032

Doxorubicin Market - Doxorubicin Market Analysis by Formulation (Lyophilized Doxorubicin Powder & Doxorubicin Solution) By Type (Breast Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Bladder Cancer, Stomach Cancer & Leukemia) By Distribution Channel & Region – Global Market Insights 2026

Microplate Systems Market - Microplate Systems Market Analysis by Product (Microplate Readers, Microplate Pipetting Systems & Dispensers, Microplate Washers), by End User, by Region - Global Forecast 2022-2026

Drug Discovery Services Market - Drug Discovery Services Market Analysis by Process (Target Selection, Target Validation, Hit-To-Lead Identification), by Type (Medicinal Chemistry, Biology Services, Pharmacokinetics), by Drug Type (Small Molecules and Biologics) by Therapeutic Area, by Region - Global Forecast 2022-2032

Lab Automation Market - Lab Automation Market by Product (Lab Automation Equipment, Microplate Readers, Automated ELISA Systems), by Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions), by End User, by Region - Global Insights 2022-2032

Animal Model Market - Animal Model Market Analysis by Species (Rat Models, Mice Models, Guinea Pig Models, Rabbit Models, Monkey Models), by Application (Basic & Applied Research, Drug Discovery/Development), by End User, by Region - Global Forecast 2022-2032

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.


Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-158
Follow Us: LinkedIn | Twitter

Back to news